DKSH signs agreement with Hanseo Chemical

Published: 4-Nov-2011
Ingredients Finance

To distribute glycerophosphatidylcholin (GPC) to the pharmaceutical industry worldwide


DKSH has signed an exclusive agreement with Hanseo Chemical (HanseoChem) of Korea, in which it will sell HanseoChem’s glycerophosphatidylcholin (GPC) to the pharmaceutical industry worldwide.

DKSH says it will help HanseoChem grow its business and enhance its product coverage worldwide. In addition, the chemicals and food ingredients distributor will support HanseoChem in the development and expansion of its soy derived active pharmaceutical ingredients (APIs) business.

  • Companies:
  • DKSH Performance Materials
See more

You may also like

Distribution

DKSH partners with IOI Oleo in Asia Pacific

Read more
IOI Oleo produces a range of oleochemical products for industrial applications, such as APIs and excipients for the pharmaceutical industry

Trending Articles

  1. CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
  2. The evolution of the pharma industry: From reactive to disruptive Globally, the pharma industry has witnessed waves of changes during the last century; we have evolved, writes Ajit Kanetkar, Head, Process Technology, ACG, from maintaining a conservative outlook and being solely reactive to disease and healthcare issues to having a radical and disruptive approach
  3. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  4. Highly potent APIs: Hazards in classification and handling This variability and subjective nature of classification means that the OEL is best considered as a tool for site risk management teams
  5. Small molecules: big market opportunities The rapid rise of biologic drugs in recent years has been accompanied by a market narrative that suggests that innovation and new treatments will be fuelled by breakthroughs in this area, leading to a decline in the small molecule pipeline. This is far from true, notes Kevin Cook, Chief Executive Officer at Sterling Pharma Solutions; both are increasing and small molecule drugs continue to be a mainstay of many drug development portfolios

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

You may also like

Distribution

DKSH partners with IOI Oleo in Asia Pacific

IOI Oleo produces a range of oleochemical products for industrial applications, such as APIs and excipients for the pharmaceutical industry
Finance

DKSH enters European distribution agreement with Omya

The distributor was reportedly chosen for its expansive network and strong service capabilities
Ingredients

Biocon collaborates to commercialise generic formulas in South East Asia

Biocon Pharma and DKSH Business Unit Healthcare have signed an agreement under which DKSH will sell and distribute seven of Biocon Pharma's generic formulations in Singapore and Thailand
Finance

Novo Nordisk Pharmatech A/S signs Asia Pacific distribution agreement with DKSH

The Danish pharma company and the Swiss market expansion expert have partnered to provide high-quality cGMP quaternary ammonium compounds in eleven markets across the region
Ingredients

DKSH signs exclusive distribution agreement with Abitec

The ingredients and specialty chemicals distributor has been selected to exclusively distribute a lipid excipient and nutritional supplement range in Thailand, Spain and Portugal
Ingredients

DKSH promotes pharmaceutical portfolio at CPhI Worldwide

DKSH, the leading market expansion services provider with a focus on Asia, showcases its pharmaceutical portfolio, innovations, solutions and concepts at CPhI Worldwide 2016 in Barcelona, Spain
Ingredients

DKSH acquires Swiss specialty chemicals distributor

The acquisition of Staerkle & Nagler will extend DKSH\'s reach into Europe
Subscribe now